Trademark: 77377366
Status Date
Monday, January 4, 2010
Filing Date
Tuesday, January 22, 2008
Abandoned Date
Wednesday, December 2, 2009
42 Consulting and advisory services relating to diagnostic preparations and products, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, development, testing and efficacy of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments namely, development, testing and efficacy, of apparatus and diagnostic instruments for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, provision of assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues; Design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic tests, including the devising, compiling and testing of algorithms and mathematical systems for predicting response to a pharmaceutical product based on individual genetic profile; Scientific research related to pharmacogenetics; Research and advisory services relating to pharmaceuticals
44 Medical diagnostic services; Medical diagnostic testing relating to the human body, namely, analysis of samples to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Medical diagnostic testing relating to the human body, namely, analysis of samples to confirm diagnosis of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Medical clinical services, namely, analysis of samples of DNA, RNA and bodily tissues to prescribe the prescribe the most efficient and/or efficacious pharmaceutical product to the patient; Medical clinical services, namely, the taking of samples of bodily tissues for analysis in connection with the prescription of pharmaceuticals or other medical treatment; Medical and scientific research in the nature of conducting clinical trials; Compilation of medical reports relating to prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Compilation of medical reports relating to confirmation of diagnosis of diseases and disorders of the body, and prescription of most efficient and efficacious pharmaceutical product or method for treatment thereof; Compilation of medical reports as a resource of phenotypic and genotypic data relating to diseases and disorders of the central nervous system and psychiatric diseases and disorders; Conducting medical examinations for diagnosis and treatments of disease; Testing and profiling of pharmaceutical preparations and treatments for medical purposes; Computer aided diagnostic testing services relating to the human body
Jan 4, 2010
Abandonment Notice Mailed - Failure To Respond
Jan 4, 2010
Abandonment - Failure To Respond Or Late Response
Jun 1, 2009
Notification Of Inquiry As To Suspension E-Mailed
Jun 1, 2009
Inquiry To Suspension E-Mailed
Jun 1, 2009
Suspension Inquiry Written
Jun 1, 2009
Lie Checked Susp - To Atty For Action
May 28, 2009
Assigned To Lie
Nov 28, 2008
Notification Of Letter Of Suspension E-Mailed
Nov 28, 2008
Letter Of Suspension E-Mailed
Nov 28, 2008
Suspension Letter Written
Nov 18, 2008
Teas/Email Correspondence Entered
Nov 18, 2008
Correspondence Received In Law Office
Nov 18, 2008
Assigned To Lie
Nov 5, 2008
Teas Response To Office Action Received
May 5, 2008
Notification Of Non-Final Action E-Mailed
May 5, 2008
Non-Final Action E-Mailed
May 5, 2008
Non-Final Action Written
Apr 29, 2008
Assigned To Examiner
Jan 26, 2008
Notice Of Pseudo Mark Mailed
Jan 25, 2008
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
